Alcohol Use Disorder Clinical Trials in New York, New York

5 studies are recruiting for alcohol use disorder in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD

   This is a double-blind, randomized, placebo-controlled Phase 2 mechanistic clinical trial designed to evaluate the therapeutic neural mechanisms of psilocybin in patients with alcohol use disorder (AUD), and to determine whether further studies are warranted to study the relationship of any such ef…

   Stage

   Phase 2

   Ages

   18 to 65

   Site

   NYU Langone Health, New York, New York

   Run by

   NYU Langone Health

   See if you can join NCT06349083 on ClinicalTrials.gov

2. An Effectiveness Trial of the PrEP for WINGS Study

   (Effectiveness Aim 1) To test the comparative effectiveness of PreP for WINGS versus PrEP alone on primary outcomes of increasing PrEP initiation measured by self-report/medical records, recent adherence and longer-term adherence by self-report/medical records over the 6-month follow-up; and second…

   Stage

   Not phased

   Ages

   18 and older

   Site

   The Columbia Community Partnership for Health, New York, New York

   Run by

   Columbia University

   See if you can join NCT06853314 on ClinicalTrials.gov

3. Anxiety During Abstinence in AUD

   The goal of this study is to better understand the underlying neurobiological basis of anxiety that emerges during abstinence in patients with alcohol use disorder (AUD). The main questions it aims to answer are: 1. To characterize anxiety itself as well as anxiety related-neurobiological circuitry…

   Stage

   EARLY_Phase 1

   Ages

   21 to 55

   Site

   Columbia University Irving Medical Center, New York, New York

   Run by

   Columbia University

   See if you can join NCT06793488 on ClinicalTrials.gov

4. Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD

   This is a double-blind, 2-group randomized controlled trial evaluating the effects of topiramate versus placebo in patients with comorbid PTSD and moderate-to-severe AUD. This trial will provide one of the first rigorous tests of whether the effects of topiramate in AUD generalize to patients with …

   Stage

   Phase 2

   Ages

   18 to 70

   Site

   New York University School of Medicine, New York, New York

   Run by

   NYU Langone Health

   See if you can join NCT03667846 on ClinicalTrials.gov

5. The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking

   The proposed project tests the efficacy of glutamate modulators in non-depressed individuals with alcohol use disorder (AUD); the primary hypothesis is that the glutamate modulator being tested reduces heavy drinking days compared to the active control. It also aims to investigate, using a 2 by 2 f…

   Stage

   Phase 2

   Ages

   21 to 70

   Site

   NYSPI, New York, New York

   Run by

   New York State Psychiatric Institute

   See if you can join NCT04084860 on ClinicalTrials.gov